Loading...
Docoh
Log in Free sign up

Orthofix Medical (OFIX)

Orthofix Medical Inc. is a global medical device and biologics company with a spine and extremities focus. The Company's mission is to deliver innovative, quality-driven solutions as it partners with health care professionals to improve patients' lives. Headquartered in Lewisville, Texas, Orthofix's spine and orthopedic extremities products are distributed in more than 70 countries via the Company's sales representatives and distributors.

Company profile

Ticker
OFIX
Exchange
NASDAQ
Website
www.orthofix.com
CEO
Jon C. Serbousek
Employees
Location
Texas
Fiscal year end
Dec 31
Sector
Manufacturing > Surgical and Medical Instrument Manufacturing
Industry (SIC)
Surgical & Medical Instruments & Apparatus
3M • Baxter International • Boston Scientific • Stryker • Becton, Dickinson And • Teleflex • Resmed • Hill-Rom • Nuvasive • Integra Lifesciences ...
Former names
ORTHOFIX INTERNATIONAL N V
SEC CIK
0000884624
Corporate docs
Subsidiaries
Orthofix Australia • Orthofix do Brasil Ltda. • Orthofix S.A. • Orthofix GmbH • Orthofix Spine GmbH • Orthofix S.r.l. • Orthofix Netherlands B.V. • Implantes y Sistemas Medicos, Inc. • Orthofix AG • Orthofix Limited ...

OFIX stock data

News

From Benzinga Pro
Stocks That Hit 52-Week Lows On Tuesday
9 Aug 22
On Tuesday, 73 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Monday
8 Aug 22
On Monday, 15 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
5 Aug 22
On Friday, 72 companies set new 52-week lows.
Recap: Orthofix Medical Q2 Earnings
5 Aug 22
Orthofix Medical Q2 EPS $0.08 Misses $0.10 Estimate, Sales $118.07M Miss $118.25M Estimate
5 Aug 22

Press releases

From Benzinga Pro
Orthofix Reports Second Quarter 2022 Results
5 Aug 22
Net sales of $118.1 million, a decrease of 3% on a reported basis and flat on a constant currency basis over prior year Global Orthopedics net sales growth of 11% on a constant currency basis driven by new products
Orthofix Medical Schedules Second Quarter Earnings Release and Conference Call for August 5, 2022
27 Jul 22
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that it will release its second quarter 2022 financial results before market open on Friday,
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
26 Jul 22
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the limited market release and first patient implant of the Virtuos™ Lyograft, a
Orthofix Medical and LimaCorporate Announce Partnership to Provide Solution for Patients with High Hip Dislocation for the US Market
13 Jul 22
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Orthofix Medical Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
2 Jun 22

Calendar

5 Aug 22
12 Aug 22
31 Dec 22

Financial summary

Financial statements Chart OFIX financial data
Quarter (USD) Jun 22 Mar 22 Dec 21 Sep 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20 Dec 19 Dec 18
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 59.54M 59.54M 59.54M 59.54M 59.54M 59.54M
Cash burn (monthly) 4.13M 1.75M (no burn) 824K 1.64M (no burn)
Cash used (since last report) 6.01M 2.54M n/a 1.2M 2.38M n/a
Cash remaining 53.53M 56.99M n/a 58.34M 57.15M n/a
Runway (months of cash) 13.0 32.6 n/a 70.8 34.9 n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Recent insider trades

OFIX insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
5 Aug 22 Jon Carl Serbousek Common Stock Payment of exercise Dispose F No No 22.77 1,450 33.02K 188,920
6 Jun 22 Paolucci Michael E Common Stock Grant Acquire A No No 0 6,383 0 33,903
6 Jun 22 Marks Lilly Common Stock Grant Acquire A No No 0 6,383 0 37,520
6 Jun 22 West Thomas A. Common Stock Grant Acquire A No No 0 6,383 0 6,543
6 Jun 22 Sicard John Common Stock Grant Acquire A No No 0 6,383 0 21,615
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Institutional ownership, Q1 2022

OFIX institutional ownership history Ownership history
13F holders Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio – – –
Largest owners Shares Value Change
Largest transactions Shares Bought/sold Change
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Financial report summary

?
Competition
Medtronic • Stryker • Fuse Medical • Track • Zimmer Biomet • Nuvasive • Globus Medical • OrthoPediatrics • Xtant Medical • Wright Medical
Management Discussion
  • Gross profit increased $44.9 million, or 14.7%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
8th grade Avg
New words: aggregate, anniversary, August, autograft, caution, CGBio, channel, chronic, competitive, departure, Description, dislocation, Dollar, education, Euro, factor, FiberFuse, flat, force, fully, guidance, high, hip, July, kind, launch, leadership, LimaCorporate, Lyograft, macro, macroeconomic, morphogenetic, partly, partnership, prepaid, prohibit, promote, put, reallocate, recombinant, resumed, seek, solution, staffing, stemming, study, substitute, surgeon, synthetic, Topic, upfront
Removed: began, full, March, newly, owed, receiving, recoup, recovery, reduced, repaid, spending, supplier
From filing 10-Q 2022 Q2
Financial reports
View all
10-Q
2022 Q2
Quarterly report
5 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
25 Feb 22
10-Q
2021 Q3
Quarterly report
5 Nov 21
10-Q
2021 Q2
Quarterly report
6 Aug 21
10-Q
2021 Q1
Quarterly report
30 Apr 21
10-K
2020 FY
Annual report
26 Feb 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
10-Q
2020 Q1
Quarterly report
8 May 20
Current reports
View all
8-K
Orthofix Reports Second Quarter 2022 Results
5 Aug 22
8-K
Departure of Directors or Certain Officers
7 Jun 22
8-K
Orthofix Reports First Quarter 2022 Results
6 May 22
8-K
Orthofix Announces New Business Unit President
8 Apr 22
8-K
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
25 Feb 22
8-K
Orthofix Announces Preliminary 2021 Fourth Quarter and Full Year Net Sales Results
10 Jan 22
8-K
Orthofix Announces Appointment of Thomas A. West to Board of Directors
14 Dec 21
8-K
Orthofix Reports Third Quarter 2021 Results
5 Nov 21
8-K
Orthofix Provides Business Update
29 Sep 21
8-K
Orthofix Announces Appointment of Wayne Burris to Board of Directors
23 Sep 21
Registration and prospectus
View all
S-8
Registration of securities for employees
6 Aug 21
S-8
Registration of securities for employees
6 Aug 21
S-8
Registration of securities for employees
13 Sep 20
S-8
Registration of securities for employees
10 Jun 20
S-8
Registration of securities for employees
5 Aug 19
S-8
Registration of securities for employees
3 Feb 19
S-8
Registration of securities for employees
1 Aug 18
S-8
Registration of securities for employees
1 Aug 18
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Aug 18
S-8 POS
Registration of securities for employees (post-effective amendment)
1 Aug 18
Proxies
View all
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
DEFR14A
Revised proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
29 Apr 21
DEF 14A
Definitive proxy
29 Apr 21
DEFR14A
Revised proxy
20 May 20
DEFR14A
Revised proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
29 Apr 20
DEF 14A
Definitive proxy
29 Apr 20
DEFA14A
Additional proxy soliciting materials
29 Apr 19
Other
View all
SD
Conflict minerals disclosure
31 May 22
SD
Conflict minerals disclosure
1 Jun 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
30 May 19
EFFECT
Notice of effectiveness
10 Aug 18
SD
Conflict minerals disclosure
30 May 18
EFFECT
Notice of effectiveness
30 May 18
CORRESP
Correspondence with SEC
23 May 18
CT ORDER
Confidential treatment order
26 Mar 18
UPLOAD
Letter from SEC
16 Aug 17
Ownership
View all
4
Orthofix Medical / Jon Carl Serbousek ownership change
8 Aug 22
4
Orthofix Medical / CATHERINE M BURZIK ownership change
8 Jun 22
4
Orthofix Medical / WAYNE BURRIS ownership change
8 Jun 22
4
Orthofix Medical / Jason Hannon ownership change
8 Jun 22
4
Orthofix Medical / James F. Hinrichs ownership change
8 Jun 22
4
Orthofix Medical / Thomas A. West ownership change
8 Jun 22
4
Orthofix Medical / JOHN SICARD ownership change
8 Jun 22
4
Orthofix Medical / Michael E Paolucci ownership change
8 Jun 22
4
Orthofix Medical / LILLY MARKS ownership change
8 Jun 22
4
Orthofix Medical / Kevin J. Kenny ownership change
13 Apr 22

Patents

View all
Utility
Bone plate
9 Aug 22
The present invention relates to an internal fixator device (1) of the bone plate type to be used as synthesis means in anatomical regions or epiphyses/metaphyses with poor coating of soft tissue, of the type comprising a two-lobe or eight-shaped bone plate (2) comprising a pair of lobed portions (23, 24) which are linked by a central linking portion (15) and in each of which at least one through-hole (3, 4) is formed to receive a corresponding bone fixation screw (5).
Utility
Quick Attachment Clamp for External Fixation Systems
21 Jul 22
A clamp for an external fixator, preferably of the quick attachment type comprises at least one first attachment provided with at least one bar housing seat for a bar of the external fixator and/or with at least one screw housing seat for a bone screw; at least one second attachment provided with at least one bar housing seat; a connector which, in a tightened configuration, passes through said first attachment and said second attachment locking the bars and/or bone screws within the bar housing seats and/or the screw housing seats; and which, in an open configuration, frees the entrance to at least the bar housing seat of said second attachment; and auxiliary connection means between said first attachment and said second attachment which are active in said open configuration.
Utility
Systems and Methods for Musculoskeletal Tissue Treatment
9 Jun 22
A system and method for pulsed electromagnetic fields (PEMF) tissue engineering enhances musculoskeletal tissue stimulation.
Utility
Bone fixation system and methods of use
31 May 22
A bone fixation system is provided for use in the spine between vertebrae.
Utility
Bone fixation system and methods of use
31 May 22
A bone fixation system is provided for use in the spine between vertebrae.

Transcripts

View all
2022 Q2
Earnings call transcript
7 Aug 22
2022 Q1
Earnings call transcript
6 May 22
2021 Q4
Earnings call transcript
25 Feb 22
2021 Q3
Earnings call transcript
5 Nov 21
2021 Q2
Earnings call transcript
8 Aug 21
2021 Q1
Earnings call transcript
30 Apr 21
2020 Q4
Earnings call transcript
26 Feb 21
2020 Q3
Earnings call transcript
8 Nov 20
2020 Q2
Earnings call transcript
9 Aug 20
2020 Q1
Earnings call transcript
8 May 20

Reddit threads

View all